About: Teneliximab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials.

Property Value
dbo:abstract
  • Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials. (en)
dbo:casNumber
  • 299423-37-3
dbo:fdaUniiCode
  • G0MV33WQ6V
dbo:kegg
  • D06071
dbo:wikiPageID
  • 9133575 (xsd:integer)
dbo:wikiPageLength
  • 2071 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1059921147 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 299423 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:kegg
  • D06071 (en)
dbp:mabType
  • mab (en)
dbp:source
  • xi/o (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • G0MV33WQ6V (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 470601929 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Teneliximab is a chimeric monoclonal antibody binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials. (en)
rdfs:label
  • Teneliximab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License